山东威高集团医用高分子制品股份有限公司（01066）于2026年2月3日发布翌日披露报表，公告显示公司在香港联交所进行股份回购，涉及回购股份数量为140,000股，占回购前已发行股本约0.0032%。回购价格介乎每股5.00港元至5.07港元，共计支付约706,600港元。
经上述回购后，公司已发行股份由4,481,985,924股降至4,481,845,924股，库藏股则增加至40,486,400股，合并计算公司总股份数保持在4,522,332,324股。公司称该回购依据2025年5月27日通过的购回授权进行，该授权可购回股份总数为451,560,392股，截至目前已累计购回33,838,000股，占授权通过当日已发行股本约7.4936%。
公告同时确认，公司已遵守香港联合交易所有限公司证券上市规则及相关法律法规的规定。该公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.